Literature DB >> 7557380

Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities.

J P Lydon1, F J DeMayo, C R Funk, S K Mani, A R Hughes, C A Montgomery, G Shyamala, O M Conneely, B W O'Malley.   

Abstract

Although progesterone has been recognized as essential for the establishment and maintenance of pregnancy, this steroid hormone has been recently implicated to have a functional role in a number of other reproductive events. The physiological effects of progesterone are mediated by the progesterone receptor (PR), a member of the nuclear receptor superfamily of transcription factors. In most cases the PR is induced by estrogen, implying that many of the in vivo effects attributed to progesterone could also be the result of concomitantly administered estrogen. Therefore, to clearly define those physiological events that are specifically attributable to progesterone in vivo, we have generated a mouse model carrying a null mutation of the PR gene using embryonic stem cell/gene targeting techniques. Male and female embryos homozygous for the PR mutation developed normally to adulthood. However, the adult female PR mutant displayed significant defects in all reproductive tissues. These included an inability to ovulate, uterine hyperplasia and inflammation, severely limited mammary gland development, and an inability to exhibit sexual behavior. Collectively, these results provide direct support for progesterone's role as a pleiotropic coordinator of diverse reproductive events that together ensure species survival.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7557380     DOI: 10.1101/gad.9.18.2266

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  534 in total

1.  Cerebellar granule cell-specific and inducible expression of Cre recombinase in the mouse.

Authors:  M Tsujita; H Mori; M Watanabe; M Suzuki; J Miyazaki; M Mishina
Journal:  J Neurosci       Date:  1999-12-01       Impact factor: 6.167

Review 2.  Mammary gland growth and development from the postnatal period to postmenopause: ovarian steroid receptor ontogeny and regulation in the mouse.

Authors:  J L Fendrick; A M Raafat; S Z Haslam
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-01       Impact factor: 2.673

Review 3.  Progesterone signaling and mammary gland morphogenesis.

Authors:  G Shyamala
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-01       Impact factor: 2.673

4.  Lactation defect in mice lacking the helix-loop-helix inhibitor Id2.

Authors:  S Mori; S I Nishikawa; Y Yokota
Journal:  EMBO J       Date:  2000-11-01       Impact factor: 11.598

Review 5.  Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormones.

Authors:  R K Hansen; M J Bissell
Journal:  Endocr Relat Cancer       Date:  2000-06       Impact factor: 5.678

Review 6.  The ovarian life cycle: a contemporary view.

Authors:  Chang Suk Suh; Barbara Sonntag; Gregory F Erickson
Journal:  Rev Endocr Metab Disord       Date:  2002-01       Impact factor: 6.514

Review 7.  Local role of progesterone in the ovary during the periovulatory interval.

Authors:  Charles L Chaffin; Richard L Stouffer
Journal:  Rev Endocr Metab Disord       Date:  2002-01       Impact factor: 6.514

8.  Improved docking, screening and selectivity prediction for small molecule nuclear receptor modulators using conformational ensembles.

Authors:  So-Jung Park; Irina Kufareva; Ruben Abagyan
Journal:  J Comput Aided Mol Des       Date:  2010-05-09       Impact factor: 3.686

Review 9.  Elucidation of a role for stromal steroid hormone receptors in mammary gland growth and development using tissue recombinants.

Authors:  G R Cunha; P Young; Y K Hom; P S Cooke; J A Taylor; D B Lubahn
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-10       Impact factor: 2.673

10.  PTEN overexpression suppresses proliferation and differentiation and enhances apoptosis of the mouse mammary epithelium.

Authors:  Joëlle Dupont; Jean Pierre Renou; Moshe Shani; Lothar Hennighausen; Derek LeRoith
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.